REVANATX.COM: Keyword Density Checker

Total words: 2238 | 2-word phrases: 591 | 3-word phrases: 650 | 4-word phrases: 665

PAGE INFO

Title	Try to keep the title under 60 characters (41 characters) Home - Re-Vana: Making Great Drugs Better
Description	Try to keep the meta description between 50 - 160 characters (120 characters) Re-Vana is developing sustained release ocular biologics. In addition, we can reduce the need for topical drug delivery.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (25 characters) MAKING GREAT DRUGS BETTER

#	Keyword	Frequency	Density
1	more about our	4	0.62%
2	global prevalence of	3	0.46%
3	of api release	3	0.46%
4	cheng c 2020	2	0.31%
5	photocrosslinking crosslink density	2	0.31%
6	of glaucoma and	2	0.31%
7	prevalence of glaucoma	2	0.31%
8	delivered in the	2	0.31%
9	is a patented	2	0.31%
10	2020 global prevalence	2	0.31%
11	c 2020 global	2	0.31%
12	internally develop a	2	0.31%
13	of glaucoma burden	2	0.31%
14	and cheng c	2	0.31%
15	t and cheng	2	0.31%
16	aung t and	2	0.31%
17	h aung t	2	0.31%
18	develop a 6	2	0.31%
19	quigley h aung	2	0.31%
20	li x wong	2	0.31%
21	about our biodegradable	2	0.31%
22	projections of glaucoma	2	0.31%
23	small molecule therapeutic	2	0.31%
24	tham y li	2	0.31%
25	board of directors	2	0.31%
26	the rate and	2	0.31%
27	rate and duration	2	0.31%
28	up to 6	2	0.31%
29	and duration of	2	0.31%
30	duration of api	2	0.31%

#	Keyword	Frequency	Density
1	internally develop a 6	2	0.30%
2	global prevalence of glaucoma	2	0.30%
3	and duration of api	2	0.30%
4	rate and duration of	2	0.30%
5	the rate and duration	2	0.30%
6	more about our biodegradable	2	0.30%
7	aung t and cheng	2	0.30%
8	t and cheng c	2	0.30%
9	quigley h aung t	2	0.30%
10	and cheng c 2020	2	0.30%
11	cheng c 2020 global	2	0.30%
12	c 2020 global prevalence	2	0.30%
13	2020 global prevalence of	2	0.30%
14	prevalence of glaucoma and	2	0.30%
15	h aung t and	2	0.30%
16	projections of glaucoma burden	2	0.30%
17	of glaucoma burden through	2	0.30%
18	y li x wong	2	0.30%
19	tham y li x	2	0.30%
20	glaucoma burden through 2040	2	0.30%
21	duration of api release	2	0.30%
22	duration of 6 to	1	0.15%
23	of 6 to 12	1	0.15%
24	months factors influencing the	1	0.15%
25	factors influencing the rate	1	0.15%
26	influencing the rate and	1	0.15%
27	of api release from	1	0.15%
28	making great drugs better	1	0.15%
29	include the choice of	1	0.15%
30	a duration of 6	1	0.15%
31	for a duration of	1	0.15%
32	µgday for a duration	1	0.15%
33	4 µgday for a	1	0.15%
34	of 4 µgday for	1	0.15%
35	rates of 4 µgday	1	0.15%
36	release rates of 4	1	0.15%
37	higher release rates of	1	0.15%
38	oculief include the choice	1	0.15%
39	of bio degradable polymers	1	0.15%
40	the choice of bio	1	0.15%